PEKIN, 2 stycznia 2024 r. /PRNewswire/ — Jak podkreślił chiński prezydent Xi Jinping w minioną niedzielę podczas orędzia noworocznego wygłoszonego w Pekinie, nadrzędnym celem Chin jest zapewnienie lepszej jakości życia ludzi. „Nasze dzieci powinny być otoczone opieką i otrzymywać wysokiej jakości edukację. Młodzi ludzie powinni mieć możliwość rozwijania kariery i odnoszenia sukcesów. Z kolei ludzie… Continue reading CGTN: Chiny zamierzają zapewnić lepszą jakość życia w perspektywie roku 2024
Category: Newswire
Emissary Launches Innovative Sales Intelligence Platform, Emissary Knowledge, Giving Sales Leaders an Information Advantage.
NEW YORK, Jan. 2, 2024 /PRNewswire/ — In a significant evolution of the sales intelligence marketplace, Emissary today unveiled Emissary Knowledge. Unlike conventional intelligence tools which scrape publicly available information from the Web, Emissary’s firsthand insights are sourced directly from executives who worked inside target accounts – drilling into the realities of what, why, and how… Continue reading Emissary Launches Innovative Sales Intelligence Platform, Emissary Knowledge, Giving Sales Leaders an Information Advantage.
Agriculture & Natural Solutions Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing January 2, 2024
NEW YORK, Jan. 2, 2024 /PRNewswire/ — Agriculture & Natural Solutions Acquisition Corporation (NASDAQ: ANSCU) (the “Company”) announced that, commencing January 2, 2024, holders of the units sold in the Company’s initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units. No fractional warrants will be… Continue reading Agriculture & Natural Solutions Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing January 2, 2024
South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials
Phase 1 data demonstrate that SRP-001 exhibits an exceptionally strong safety and robust pharmacokinetic profile and is well-toleratedWell-designed Phase 2 trials set to show statistical significance compared to placebo and positive control NEW ORLEANS, Jan. 2, 2024 /PRNewswire/ — South Rampart Pharma, Inc. (“South Rampart” or the “Company”), a clinical-stage life science company focused on… Continue reading South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials
Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index lanzado en Pekín
PEKÍN, 2 de enero de 2024 /PRNewswire/ — El Xinhua-Yushu Wild Cordyceps Sinensis Price Index fue lanzado oficialmente el 27 de diciembre en Pekín, capital de China, lo que indica el desarrollo acelerado de la industria de cordyceps sinensis silvestre hacia una nueva etapa digital, informativa y moderna. Continue Reading Photo shows the launching ceremony… Continue reading Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index lanzado en Pekín
Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients
CAMBRIDGE, Mass. , Jan. 2, 2024 /PRNewswire/ — Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that enrollment has been completed in the randomized controlled Part C of the DisTinGuish study evaluating DKN-01, Leap’s anti-Dickkopf-1 (DKK1) antibody, in combination with tislelizumab, BeiGene’s anti-PD-1 antibody, and chemotherapy in patients with… Continue reading Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients
Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NEW HAVEN, Conn., Jan. 2, 2024 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) today announced that Vlad Coric, M.D., Chairman and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California, on Monday, January 8, 2024 at 8:15 am (PT). A slide deck of the presentation will be available on… Continue reading Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BlipCut Introduces AI Video Translator: A Brand-New AI Tool
NEW YORK, Jan. 2, 2024 /PRNewswire/ — BlipCut, a fresh face in the tech scene, is thrilled to unveil its latest creation: BlipCut AI Video Translator. This online tool is set to transform the way content is created and shared, opening up new possibilities for users of all levels. AI Features: Continue Reading BlipCut Introduces AI… Continue reading BlipCut Introduces AI Video Translator: A Brand-New AI Tool
UNITED VAN LINES 47th ANNUAL NATIONAL MOVERS STUDY REVEALS WHERE AND WHY AMERICANS MOVED IN 2023
Western States Top the High Outbound List as Americans Flock to the Southeast and Less Expensive Metros ST. LOUIS, Jan. 2, 2024 /PRNewswire/ — United Van Lines released the company’s 47th Annual National Movers Study today, which indicates Americans are moving eastbound and southbound – and relocating to less expensive areas with comparable amenities to… Continue reading UNITED VAN LINES 47th ANNUAL NATIONAL MOVERS STUDY REVEALS WHERE AND WHY AMERICANS MOVED IN 2023
Harvest Partners Announces Promotions
NEW YORK, Jan. 2, 2024 /PRNewswire/ — Harvest Partners, LP (“Harvest” or “the Firm”) is pleased to announce the promotions of Shane McHugh to Principal and Claire Simon to Vice President. “We congratulate Shane and Claire on these well-deserved advancements,” said Michael DeFlorio, Chief Executive Officer at Harvest. “They have each contributed uniquely and significantly… Continue reading Harvest Partners Announces Promotions